Hematology

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.

The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.

The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.

The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.

The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.